| Textual Information(1) |
1) The standalone financial results of Jio Financial Services Limited (hereinafter referred to as the Company) for the quarter ended June 30, 2026 have been prepared in accordance with recognition and measurement principles of the Indian Accounting Standards (Ind-AS) 34 Interim Financial Reporting as notified under section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder as amended from time to time and in compliance with Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (hereinafter referred to as the SEBI Regulations) and other recognised accounting practices generally accepted in India along with the circulars, guidelines and directions issued by the Reserve Bank of India (hereinafter referred to as the RBI) from time to time. These standalone financial results have been reviewed and recommended by the Audit Committee in its meeting held on July 16, 2026 and approved by the Board of Directors in their meeting held on the same date. These financial results are available on the website of the Company viz. https://www.jfs.in and on the website of BSE Limited (BSE) (www.bseindia.com) and National Stock Exchange of India Limited (NSE) (www.nseindia.com). 2) The joint statutory auditors of the Company have carried out limited review of the aforesaid results as required in terms of Regulation 33 of the SEBI Regulations and have given an unmodified conclusion in their review report. 3) The Company is currently engaged primarily in the business of investing in India, which constitutes its sole reporting segment in accordance with Ind AS 108 Operating Segments. 4) The Company, on September 3, 2025, had allotted 25 crore warrants each at a price of Rs. 316.50 per warrant, by way of preferential issue on private placement basis, to Sikka Ports & Terminals Limited and Jamnagar Utilities & Power Private Limited, entities forming part of the promoter group of the company, upon receipt of Rs. 3,956.25 crore, being 25% of total issue price of the said warrants. Each warrant is convertible by the holder thereof on or before expiry of 18 months from the date of allotment into one fully paid-up equity share of Rs. 10 each of the Company. On April 21, 2026, the Company allotted 12.5 crore equity shares of face value of Rs. 10 each at a premium of Rs. 306.50 per share, each to the above promoter group companies, upon receipt of Rs. 5,934.38 crore, being balance 75% of the issue price of the warrants. Post-allotment, the paid-up equity share capital of the Company has increased from Rs. 6,353.14 crore (635.31 crore equity shares) to Rs. 6,603.14 crore (660.31 crore equity shares) and the total promoter and promoter group shareholding has become 49.13% from 47.12%. The remaining 25 crore warrants are outstanding as on June 30, 2026. 5) The Board of Directors of the Company, at its meeting held on April 22, 2026, approved the formation of a 50:50 joint venture company with Allianz Europe B.V. (“Allianz”) for carrying on general insurance business (including health insurance) in India and a joint venture agreement to the effect was executed on the said date. Subsequently, on May 12, 2026, the Company and Allianz on receipt of no objection certificate from Insurance Regulatory and Development Authority of India (IRDAI), have incorporated a joint venture company named “Jio Allianz General Insurance Limited” (JAGIL”), to carry on the general insurance business subject to regulatory approvals for which necessary applications have been made by JAGIL. During the quarter, the Company and Allianz have made an investment of Rs. 4.95 crore each towards equity share capital of JAGIL. 6) The figures for the quarter ended March 31, 2026 are the balancing figures between audited figures in respect of the full financial year ended March 31, 2026 and the published unaudited year to date figures upto December 31, 2025 being the end of the third quarter, which were subjected to limited review by the statutory auditors of the Company. 7) The figures for the previous periods/ year have been regrouped/ reclassified, wherever necessary, to make them comparable with those of the current period. |
Format for Reporting Segment wise Revenue, Results and Capital Employed along with
the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-06-2026 |
30-06-2026 |
| Whether results are audited or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or consolidated |
Standalone |
Standalone |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should be disclosed) |
|
Total Segment Revenue |
|
|
|
Less: Inter segment revenue |
|
|
|
Revenue from operations |
|
|
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and interest from each segment |
|
Total Profit before tax |
|
|
|
i. Finance cost |
|
|
|
ii. Other Unallocable Expenditure net off Unallocable income |
|
|
|
Profit before tax |
|
|
| 3 |
(Segment Asset - Segment Liabilities) |
|
Segment Asset |
|
Total Segment Asset |
|
|
|
Un-allocable Assets |
|
|
|
Net Segment Asset |
|
|
| 4 |
Segment Liabilities |
|
Segment Liabilities |
|
Total Segment Liabilities |
|
|
|
Un-allocable Liabilities |
|
|
|
Net Segment Liabilities |
|
|
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-06-2026 |
30-06-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Standalone |
Standalone |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Remeasurement of the defined benefit plans |
-2800000 |
-2800000 |
| 2 |
Tax relating to the above item |
700000 |
700000 |
|
Total Amount of items that will not be reclassified to profit and loss |
-2100000 |
-2100000 |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
0.00 |
0.00 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Changes in fair value of debt instruments carried at FVTOCI |
40800000 |
40800000 |
| 2 |
Tax relating to above item |
-10300000 |
-10300000 |
|
Total Amount of items that will be reclassified to profit
and loss |
30500000 |
30500000 |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
284.00 |
284.00 |
Statement on Deviation or Variation for proceeds of Public Issue, Rights
Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Amount in (Lakhs)
| Mode of Fund Raising |
Preferential Issues |
| Description of mode of fund raising
(Applicable in case of others is selected) |
|
| Date of Raising Funds |
03-09-2025 |
| Amount Raised |
9,89,063.00 |
| Report filed for Quarter ended |
30-06-2026 |
| Monitoring Agency |
Applicable |
| Monitoring Agency Name, if applicable |
CRISIL Ratings Limited |
| Is there a Deviation / Variation in use of funds raised |
No |
| If yes, whether the same is pursuant to change in terms of a contract or objects,
which was approved by the shareholders |
|
| If Yes, Date of shareholder Approval |
|
| Explanation for the Deviation / Variation |
Not Applicable |
| Comments of the Audit Committee after review |
No Comments |
| Comments of the auditors, if any |
No Comments |
| Sr. |
Original Object |
Modified Object, if any |
Original Allocation |
Modified allocation, if any |
Funds Utilised |
Amount of Deviation/Variation for the quarter according to applicable
object |
Remarks if any |
| 1 |
Infusion of funds into existing and new subsidiaries / joint ventures |
Not Applicable |
11,86,875.00 |
0.00 |
4,92,719.00 |
0.00 |
The Company has issued convertible warrants and had received 25% of the issue size i.e. Rs 3,956.25 crore, as subscription amount during the quarter ended September 30, 2025. Further, Rs 5,934.38 crore (balance consideration i.e. 75% of the issue price) has been received on April 21, 2026 from warrant holders for conversion of 25 crore warrants. The balance consideration of Rs 5,934.38 crore will be received as and when the warrant conversion option is exercised by the warrant holders to convert warrants into equity shares during the tenure of 18 months from date of allotment of warrants i.e. by March 2027. |
| 2 |
General Corporate Purpose |
Not Applicable |
3,95,625.00 |
0.00 |
45.00 |
0.00 |
|
Signatory Details
| Name of signatory |
Annapoorna Venkataramanan |
| Designation of person |
Chief Financial Officer |
| Place |
Mumbai |
| Date |
16-07-2026 |